Filter
237
Filtered Results: 237
Text search:
Astra
Zeneca
Featured
Recommendations
29
New Publications
84
Language
Document type
Studies & Reports
63
Guidelines
50
Fact sheets
40
No document type
35
Manuals
11
Situation Updates
9
Resource Platforms
9
Strategic & Response Plan
9
Training Material
4
Infographics
3
Videos
2
Brochures
1
Online Courses
1
Countries / Regions
Brazil
16
Germany
9
East and Southern Africa
7
Argentina
7
Ukraine
6
Latin America and the Carribbean
6
West and Central Africa
6
Russia
6
Kenya
5
Syria
5
Middle East and North Africa
5
India
5
Chile
4
Nigeria
4
Africa
4
Liberia
4
Colombia
3
Global
3
Congo, Democratic Republic of
3
Western and Central Europe
3
Paraguay
3
South Africa
3
Ethiopia
3
South Sudan
3
El Salvador
2
Ghana
2
Rwanda
2
Senegal
2
Philippines
2
Namibia
2
Yemen
2
Botswana
2
Zambia
2
Lesotho
1
Sierra Leone
1
China
1
Iran
1
Malawi
1
Zimbabwe
1
Guinea
1
Mozambique
1
Guinea-Bissau
1
Tanzania
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
United Kingdom
1
South Korea
1
Belarus
1
Uganda
1
Sudan
1
Angola
1
Iraq
1
Ecuador
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
COVID-19
94
Guidelines
30
Studies & Reports
18
Policies
7
Information, Education and Communication (IEC)
5
Humanitarian Crisis
4
Diabetes
2
Drugs & Medical Equipment
2
Capacity Building
2
Statistics
2
Buruli Ulcer
1
Annual Report MEDBOX
1
x MEDBOX Issue Brief & Annual Reports x
1
Community Health
1
Infection Control & Prevention (IPC)
1
Menstrual Hygiene Management
1
Vaccine-preventable Diseases
1
Health System Strengthening
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
WASH
1
Surgery & Anaesthesia
1
Health Systems
1
Primary Health Care
1
Age & Elderly
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
58
Vaxzevria (Astra Zeneca)
26
Immunization Guidelines
14
Fair Allocation & Ethical Aspects
12
Communication Material
11
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
10
Children/Adolescents Mental Disorders
10
Access & Strategy
10
Clinical Guidelines
8
Vaccine Hesitancy & Myths
8
Hospital Readiness/Essential Health Services
7
Logistics & Supply
7
Dashboards & Resource Platforms
6
COVAX Initiative
6
Booster Doses
6
SARS-CoV-2 Variants
5
Long COVID/ Post-COVID Syndrome
5
For General Public & Community
4
Global Impact: Socio-economic, health services, TB & HIV
4
Inactivated COVID-19 Vaccines
4
Schizophrenia
3
Infection Control General
3
Training, others
3
For Health Worker
3
Appeals and Response Plans
3
Country-specific Platforms
3
Educational Settings
3
Workplace
3
Physical Distancing
3
Vector-based Vacines General
3
Research & Pipeline
3
Situation Reports & Updates
3
Posttraumatic stress disorder Adults
2
Situation Reports & Updates
2
Prevention & Preparedness
2
Studies
2
Context & Facts, Travel Advice
2
COVID-19
2
Poster & Infographics
2
COVID-19 Information
2
Faith-based Organizations
2
Scientific & Research Studies
2
Infection Control & Prevention (IPC)
2
Tips & Best Practice Examples
2
Videos
2
Vaccine Candidates & Research
2
COVID-19 Vaccination
2
mRna Vaccines general
2
Biontech/Pfizer Comirnaty
2
Advocacy & Communication
2
Situation Reports & Updates
2
Health Financing Toolbox
2
Anxiety Disorders
2
War & Conflict
1
General Reports
1
Surveillance
1
Agriculture & Veterinary
1
IPC
1
Background PTSD in children
1
Vaccines & Immunization
1
Pediatrics
1
Training Manuals
1
General Studies & Reports
1
Latin America
1
African Region
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Stress
1
General
1
Research & Development
1
Health Personnel
1
General
1
Infection Prevention & Hygiene
1
Online Courses & Resources
1
Public Health
1
For Parents & Children
1
For Pregnant Women
1
For People with Disabilities
1
For Migrants & Refugees
1
Dashboards & Maps
1
For Older People
1
Information for the Public
1
HIV and COVID-19
1
Mythbusters/Misinformation
1
Vaccination & Strategy
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
COVID-19 Vaccination Information
1
Moderna
1
Johnson & Johnson
1
Sputnik V
1
Covaxin
1
Hygiene
1
Primary Care
1
Community Health Workers CHW
1
Essential Medicines
1
Prices and Patents
1
Reports & Studies
1
Health Care Systems
1
General Information & Methodology
1
Global Overview
1
General
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
Bipolar Affective Disorders
1
Human Rights & the Right to Health
1
TB & Prisoners
1
Research & Access
1
Stewardship
1
Country Specific Information
1
Neurological disorders, Others
1
Training & Capacity Building
1
Preparedness & Prevention
1
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
AstraZeneca-SKBio in South Korea and Serum Institute of India
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
Learn about the composition and delivery mechanism for the new classes of COVID-19 vaccines based on adenovirus from Johnson & Johnson and AstraZeneca with Dr. Jonathan Genzen, COO of ARUP Laboratories and an Associate Professor at the University of Utah School of Medicine.
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
